Circulation, Vol 79, 1118-1124, Copyright © 1989 by American Heart Association
T Kimura, H Yasue, N Sakaino, M Rokutanda, M Jougasaki and H Araki
To study the effects of magnesium (Mg2+) on human coronary arteries and to
compare those effects with those of diltiazem and nitroglycerin, we
measured the tension of ring segments from isolated human coronary arteries
obtained at autopsy within 5 hours after death. Precontracted segments with
3 x 10(-6) M prostaglandin F2 alpha were studied after adding cumulative
concentrations of these agents (1.0-8.0 mM, 10(-9)- 10(-5) M, and
10(-10)-10(-6) M, respectively). Mg2+ significantly inhibited the tonic
contraction compared with the time-matched controls at 1.0 and 2.0 mM (48.7
+/- 5.6% vs. 88.6 +/- 2.2%, p less than 0.01, 36.2 +/- 6.1% vs. 78.9 +/-
3.0%, p less than 0.01, respectively). 1.0 and 2.0 mM Mg2+ did not
suppress, but actually increased, the amplitude of periodic contraction,
but 8.0 mM Mg2+ reduced the amplitude compared with the controls (6.6 +/-
5.2% vs. 73.3 +/- 10.7%, p less than 0.01). Diltiazem at a concentration of
10(-5) M moderately inhibited the tonic contraction, and reduced the
amplitude of periodic contraction almost completely. Nitroglycerin reduced
the tonic contraction almost completely at a concentration of 10(-6) M but
did not reduce the amplitude of periodic contraction at any concentration.
We conclude that 1.0 and 2.0 mM Mg2+ inhibits the tonic contraction and
that 8.0 mM Mg2+ inhibits the periodic as well as the tonic contraction of
isolated human coronary arteries. Diltiazem inhibits the periodic
contraction, whereas nitroglycerin suppresses tonic contraction without
affecting the periodic contraction.
ARTICLES
Effects of magnesium on the tone of isolated human coronary arteries. Comparison with diltiazem and nitroglycerin
Division of Cardiology, Kumamoto University Medical School, Japan.
This article has been cited by other articles:
![]() |
H Teragawa, M Kato, T Yamagata, H Matsuura, and G Kajiyama Magnesium causes nitric oxide independent coronary artery vasodilation in humans Heart, August 1, 2001; 86(2): 212 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shibata, K. Ueshima, M. Harada, M. Nakamura, K. Hiramori, S. Endo, N. Sato, H. Mukaida, T. Suzuki, T. Suzuki, et al. Effect of Magnesium Sulfate Pretreatment and Significance of Matrix Metalloproteinase-1 and Interleukin-6 Levels in Coronary Reperfusion Therapy for Patients with Acute Myocardial Infarction Angiology, July 1, 1999; 50(7): 573 - 582. [Abstract] [PDF] |
||||
![]() |
W. Storm and J. J. Zimmerman Magnesium Deficiency and Cardiogenic Shock After Cardiopulmonary Bypass Ann. Thorac. Surg., August 1, 1997; 64(2): 572 - 577. [Abstract] [Full Text] |
||||
![]() |
J. Caspi, E. Rudis, I. Bar, T. Safadi, and M. Saute Effects of Magnesium on Myocardial Function After Coronary Artery Bypass Grafting Ann. Thorac. Surg., April 1, 1995; 59(4): 942 - 947. [Abstract] [Full Text] |
||||
![]() |
P. A. Hertzman, G. L. Maddoux, E. M. Sternberg, M. P. Heyes, I. N. Mefford, G. M. Kephart, and G. J. Gleich Repeated Coronary Artery Spasm in a Young Woman With the Eosinophilia-Myalgia Syndrome JAMA, June 3, 1992; 267(21): 2932 - 2934. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |